Stock 9926 AKESO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Akeso, Inc.

Equities

9926

KYG0146B1032

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:22 2024-05-10 am EDT 		5-day change 1st Jan Change
49.95 HKD -1.09% Intraday chart for Akeso, Inc. +2.36% +7.65%
Apr. 24 Akeso’s Supplemental New Drug Application for Cervical Cancer Drug Accepted by Chinese Regulator MT
Apr. 24 National Medical Products Administration Accepted the Supplemental New Drug Application by Akeso, Inc. for (Cadonilimab, Pd-1/Ctla-4) as First-Line Treatment for Cervical Cancer CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bullish

Neutral

Bullish

Resistance 51.95 51.95 51.95
Spread/Res.-3.85%-3.85%-3.85%
Spread/Supp.+6.39%+28.24%+25.19%
Support 46.95 38.95 39.90

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. 9926 Stock
  4. Charts Akeso, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW